Cargando…
Tuberculosis drug discovery in the post-post-genomic era
The expectation that genomics would result in new therapeutic interventions for infectious diseases remains unfulfilled. In the post-genomic era, the decade immediately following the availability of the genome sequence of Mycobacterium tuberculosis, tuberculosis (TB) drug discovery relied heavily on...
Autores principales: | Lechartier, Benoit, Rybniker, Jan, Zumla, Alimuddin, Cole, Stewart T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927952/ https://www.ncbi.nlm.nih.gov/pubmed/24401837 http://dx.doi.org/10.1002/emmm.201201772 |
Ejemplares similares
-
Vaccines for the 21st century
por: Delany, Isabel, et al.
Publicado: (2014) -
The gut microbiome: scourge, sentinel or spectator?
por: Korecka, Agata, et al.
Publicado: (2012) -
The Drosophila melanogaster host model
por: Igboin, Christina O., et al.
Publicado: (2012) -
Treponema denticola interactions with host proteins
por: Fenno, J. Christopher
Publicado: (2012) -
Autophagy: A new strategy for host-directed therapy of tuberculosis
por: Paik, Seungwha, et al.
Publicado: (2018)